Bioluminescence Ventures - aVenture Asset Manager Research
Location
San Francisco, CA, US
Founded
2022
Bioluminescence Ventures is a US-based biotechnology venture capital firm headquartered in San Francisco. The firm focuses on investing in companies with transformational platform technologies developing first-in-class or best-in-class therapeutics. Their investment areas include breakthrough biology, drug discovery platforms, genetic medicines platforms, and computational biology platforms.
The firm's portfolio includes notable companies such as Ensoma, Nido Biosciences, ReCode Therapeutics, and Surge Therapeutics. Bioluminescence Ventures typically participates in Series B funding rounds, demonstrating their commitment to supporting companies at critical growth stages. The firm's mission-driven approach aims to translate innovative science into next-generation medicines that will impact patients' lives.
Bioluminescence Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies4
Current Portfolio Count4
Top Investment Stages
Series B4 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.
US-based Bioluminescence, a biotech venture firm, invests in transformative science for next-gen medicines, focusing on breakthrough biology, drug discovery, and computational platforms.
Bioluminescence Ventures - Similar Investment Firms
